Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Clinical Pharmacology and Therapeutics
|
April 3, 2020
Investigation and Management of Stool Frequency and Consistency Associated With SGLT1 Inhibition by Reducing Dietary Carbohydrate: A Randomized Trial
YanLing He, Jül Schofield, Ping Mahling, et al.
Drug Discovery Today
|
October 9, 2025
The R&D productivity challenge: transforming the pharmaceutical ecosystem
Alexander Schuhmacher, Oliver Gassmann, Sebastian Kwisda, et al.
Drug Discovery Today
|
May 22, 2021
R&D efficiency of leading pharmaceutical companies - A 20-year analysis
Alexander Schuhmacher, Lucas Wilisch, Michael Kuss, et al.
Drug Discovery Today
|
July 28, 2023
Analysis of pharma R&D productivity - a new perspective needed
Alexander Schuhmacher, Markus Hinder, Alexander von Stegmann Und Stein, et al.
Journal of Clinical Pharmacology
|
May 15, 2010
Effect of steady-state enoxacin on single-dose pharmacokinetics of roflumilast and roflumilast N-oxide
Gezim Lahu, Nassr Nassr, Rolf Herzog, et al.
Thrombosis and Haemostasis
|
April 21, 2005
Anticoagulant and anti-platelet effects are maintained following coadministration of otamixaban, a direct factor Xa inhibitor, with tirofiban in healthy volunteers
Markus Hinder, Anne Paccaly, Annke Frick, et al.
Clinical Pharmacology and Therapeutics
|
December 21, 2006
Direct and rapid inhibition of factor Xa by otamixaban: a pharmacokinetic and pharmacodynamic investigation in patients with coronary artery disease
Markus Hinder, Annke Frick, Pierre Jordaan, et al.
Archives of Disease in Childhood
|
March 24, 2023
Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study
Viviane Klingmann, Markus Hinder, Thomas H Langenickel, et al.
Pharmacology Research & Perspectives
|
March 18, 2022
Evaluation of cardiac parameters and other safety outcomes of brolucizumab treatment in patients with neovascular age-related macular degeneration
Nadia Zakaria, Nicolas Guerard, Andres Emanuelli, et al.
Journal of Clinical Pharmacology
|
January 7, 2006
Pharmacokinetics of otamixaban, a direct factor Xa inhibitor, in healthy male subjects: pharmacokinetic model development for phase 2/3 simulation of exposure
Anne Paccaly, Annke Frick, Shashank Rohatagi, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Clinical Pharmacology and Therapeutics
|
April 3, 2020
Investigation and Management of Stool Frequency and Consistency Associated With SGLT1 Inhibition by Reducing Dietary Carbohydrate: A Randomized Trial
YanLing He, Jül Schofield, Ping Mahling, et al.
Drug Discovery Today
|
October 9, 2025
The R&D productivity challenge: transforming the pharmaceutical ecosystem
Alexander Schuhmacher, Oliver Gassmann, Sebastian Kwisda, et al.
Drug Discovery Today
|
May 22, 2021
R&D efficiency of leading pharmaceutical companies - A 20-year analysis
Alexander Schuhmacher, Lucas Wilisch, Michael Kuss, et al.
Drug Discovery Today
|
July 28, 2023
Analysis of pharma R&D productivity - a new perspective needed
Alexander Schuhmacher, Markus Hinder, Alexander von Stegmann Und Stein, et al.
Journal of Clinical Pharmacology
|
May 15, 2010
Effect of steady-state enoxacin on single-dose pharmacokinetics of roflumilast and roflumilast N-oxide
Gezim Lahu, Nassr Nassr, Rolf Herzog, et al.
Thrombosis and Haemostasis
|
April 21, 2005
Anticoagulant and anti-platelet effects are maintained following coadministration of otamixaban, a direct factor Xa inhibitor, with tirofiban in healthy volunteers
Markus Hinder, Anne Paccaly, Annke Frick, et al.
Clinical Pharmacology and Therapeutics
|
December 21, 2006
Direct and rapid inhibition of factor Xa by otamixaban: a pharmacokinetic and pharmacodynamic investigation in patients with coronary artery disease
Markus Hinder, Annke Frick, Pierre Jordaan, et al.
Archives of Disease in Childhood
|
March 24, 2023
Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study
Viviane Klingmann, Markus Hinder, Thomas H Langenickel, et al.
Pharmacology Research & Perspectives
|
March 18, 2022
Evaluation of cardiac parameters and other safety outcomes of brolucizumab treatment in patients with neovascular age-related macular degeneration
Nadia Zakaria, Nicolas Guerard, Andres Emanuelli, et al.
Journal of Clinical Pharmacology
|
January 7, 2006
Pharmacokinetics of otamixaban, a direct factor Xa inhibitor, in healthy male subjects: pharmacokinetic model development for phase 2/3 simulation of exposure
Anne Paccaly, Annke Frick, Shashank Rohatagi, et al.
Page
of 5